We therefore reasoned that ID3 may regulate the inhibitory/activating receptor balance in macrophages, and that the control of SIRPA and dectin-1 expression may underlie at least part of the anti-tumour activities of wild-type KCs. Here, ID3 is linked to neoplasm.